Sort
17,288 grants matching “multiple sclerosis”
EPITOPE SPECIFIC T LYMPHOCYTES IN RELAPSING EAE
$188,750Oregon Health And Science University · R01 · FY2001 · NS
Post-transcriptional Regulation of Cytokine Production
$188,750Mingui Fu · University Of Missouri Kansas City · R21 · FY2014 · AI
Ikaros in mast vs. basophil lineage choice
$188,719Melissa Ann Brown · Northwestern University At Chicago · R21 · FY2011 · AI
Mining the Multiple Sclerosis miRNome for Disease Markers
$188,719Amy E Lovett-Racke · Ohio State University · R21 · FY2010 · NS
Preclinical development of a novel Nrf2-activator formulation for the treatment of idiopathic pulmonary fibrosis
$188,685Louise Hecker · University Of Arizona · R21 · FY2017 · AG
STRUCTURE/FUNCTION STUDIES OF INTERFERON TAU
$188,670University Of Florida · R01 · FY2002 · CA
Sex differences in the CNS during disease
$188,650Rhonda R Voskuhl · University Of California Los Angeles · R21 · FY2011 · NS
Genetic Mechanisms of Oligodendrogenesis and Remyelination
$188,568Magdalena A Petryniak · Oregon Health & Science University · K08 · FY2012 · NS
Kinetic image cytometry assays for neuronal activity/toxicity
$188,566Patrick M McDonough · Vala Sciences, Inc. · R41 · FY2014 · CA
Mount Sinai Neurology Resident - Researcher Training Program
$188,450Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · R25 · FY2018 · NS
An Orthogonal Bioluminescent Platform For Multiplexed Imaging And Control
$188,449Nathan Christopher Shaner · University Of California, San Diego · R21 · FY2025 · EY
Immune epitope database for Type 1 diabetes, MS, and RA
$188,436Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2009 · AI
MYELIN PO GLYCOPROTEIN: STRUCTURE &ADHESIVE MECHANISMS
$188,398Boston College · R01 · FY2002 · NS
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN SOUTHEASTERN MINNESOTA
$188,360Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · CA
Endogenous retroviruses and gene regulation after injury
$188,220Kiho Cho · University Of California At Davis · R01 · FY2006 · GM
ANIMAL MODEL CORE
$188,109Robyn S Klein · Washington University · P01 · FY2009 · NS
Selective CB2 Cannabinoid Agonists as Candidate Therapeutics for ALS
$188,053Paul L Prather · Univ Of Arkansas For Med Scis · R21 · FY2008 · NS
GENETIC RESISTANCE TO EAE
$188,015Mcp Hahnemann University · R01 · FY2000 · NS
EMOTIONS
$187,947Robert W. Levenson · University Of California, San Francisco · P01 · FY2008 · AG
Therapeutic potential of affinity enhanced pMHCII-4E reagents
$187,938Thamotharampillai Dileepan · University Of Minnesota · R21 · FY2025 · AI
Calpain Inhibitors for Cancer Related Neuropathies
$187,907Rob Webb · Axona, Inc. · R43 · FY2007 · CA
Biomarkers of the Therapeutic Response
$187,873Richard Rudick · Cleveland Clinic Lerner Com-Cwru · P50 · FY2009 · NS
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
$187,795Todd Michael Brusko · University Of Florida · R01 · FY2019 · DK
Building foundations for a neurobiology of fatigue: validating an animal model
$187,632Mary E Harrington · Smith College · R21 · FY2012 · NR
Mucosal and Peripheral NK-T Cells in HIV Infection
$187,524Otto O Yang · University Of California Los Angeles · R21 · FY2007 · AI